Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Japanese Encephalitis Virus Disease”

85 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 85 results

Large-scale testing (Phase 3)Study completedNCT01386827
What this trial is testing

Ixiaro as Booster After Mouse-brain Derived Vaccines for Japanese Encephalitis

Who this might be right for
Japanese Encephalitis
Helsinki University Central Hospital 120
Large-scale testing (Phase 3)Study completedNCT00595270
What this trial is testing

Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 349
Post-approval studies (Phase 4)Study completedNCT00463684
What this trial is testing

Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age

Who this might be right for
Japanese Encephalitis
PATH 278
Post-approval studies (Phase 4)Study completedNCT02880865
What this trial is testing

Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine

Who this might be right for
Encephalitis, JapaneseMeaslesMumps+1 more
PATH 628
Large-scale testing (Phase 3)Study completedNCT01408537
What this trial is testing

Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children

Who this might be right for
Encephalitis, Japanese B
Mahidol University 152
Large-scale testing (Phase 3)Study completedNCT01900444
What this trial is testing

Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea

Who this might be right for
Japanese Encephalitis
Sanofi Pasteur, a Sanofi Company 119
Post-approval studies (Phase 4)UnknownNCT04817917
What this trial is testing

Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province

Who this might be right for
Japanese EncephalitisVaccine Preventable DiseaseVaccine Reaction
Zhejiang Provincial Center for Disease Control and Prevention 712
Post-approval studies (Phase 4)Study completedNCT01158599
What this trial is testing

This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 200
Large-scale testing (Phase 3)Study completedNCT01662440
What this trial is testing

Safety and Immunogenicity of 2 Different Vaccination Schedules of Rabies and Japanese Encephalitis Vaccines in Healthy Adult Subjects

Who this might be right for
RabiesJapanese Encephalitis
Novartis Vaccines 661
Not applicableStudy completedNCT02933710
What this trial is testing

Postmarketing Surveillance Study for IMOJEV® in Republic of Korea

Who this might be right for
Japanese Encephalitis
Sanofi Pasteur, a Sanofi Company 50
Large-scale testing (Phase 3)Study completedNCT00595309
What this trial is testing

Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 198
Not applicableUnknownNCT06027801
What this trial is testing

Iron Fortified Food to Improve Japanese Encephalitis and Typhoid Fever Vaccine Immunogenicity

Who this might be right for
Iron Deficiency Anemia
University of Oxford 150
Large-scale testing (Phase 3)Study completedNCT01396512
What this trial is testing

Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in Toddlers

Who this might be right for
Japanese EncephalitisJapanese Encephalitis Virus Disease
Sanofi Pasteur, a Sanofi Company 274
Early research (Phase 1)WithdrawnNCT01559831
What this trial is testing

Immune Response in IXIARO Batch JEV09L37 Recipients Before and After Revaccination

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH
Testing effectiveness (Phase 2)Study completedNCT00319592
What this trial is testing

A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX

Who this might be right for
Japanese Encephalitis
Sanofi 60
Large-scale testing (Phase 3)UnknownNCT00938379
What this trial is testing

Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDR

Who this might be right for
MalariaDengueJapanese Encephalitis
London School of Hygiene and Tropical Medicine 5,000
Post-approval studies (Phase 4)Study completedNCT01398540
What this trial is testing

Cellular and Humoral Immunity in Elderly After Immunization With a Japanese Encephalitis Vaccine

Who this might be right for
Humoral and Cellular Immune Responses
Medical University of Vienna 60
Not applicableStudy completedNCT00596102
What this trial is testing

Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 3,258
Post-approval studies (Phase 4)Study completedNCT02532569
What this trial is testing

Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vaccineinj

Who this might be right for
Japanese Encephalitis
Boryung Pharmaceutical Co., Ltd 94
Post-approval studies (Phase 4)Study completedNCT01815073
What this trial is testing

Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine

Who this might be right for
Japanese EncephalitisChickenpox
Changchun Keygen Biological Products Co., Ltd. 497
Next Page